Puberty Blocker Side Effects: A Sourced Guide for Families

TransHealthHub

Sep 1

6 min read

Key Takeaways

Puberty blockers (also called puberty-pausing medication) commonly cause mild, manageable effects such as injection-site swelling, hot flashes, headaches, and mood changes, according to the Mayo Clinic.
You may see this care described as puberty blockers, hormone-suppressing medication, or puberty-pausing medication. This guide uses "puberty-pausing medication" for clarity, and the terms describe the same treatment.
The main long-term concern doctors track is bone density, since a 2020 U.S. study found lower bone density scores in transgender youth even before treatment started, a pattern clinicians now monitor closely.
Fertility, growth, and pubertal development are checked on a regular schedule, and clinicians are expected to counsel every young person on fertility preservation options before treatment begins.
A large 2026 U.S. study following more than 41,000 transgender youth found this medication was associated with lower odds of a mood disorder or suicidal thoughts diagnosis, though the study's authors caution this shows an association, not a proven cause.

The short answer

Puberty blocker side effects are usually mild during treatment (think hot flashes, headaches, and injection-site swelling), while the effects that require the most monitoring, bone density, growth, and fertility, unfold over months and years and are tracked through regular checkups. At TransHealthHub, we believe families deserve a plain, sourced answer to this question rather than either reassurance or alarm, so this guide walks through what current research and clinical guidelines actually say.

Puberty-pausing medication has been used for decades to treat early puberty in children generally, and its use for transgender adolescents follows the same clinical monitoring approach: regular bloodwork, bone scans, and growth checks throughout treatment.

What side effects are commonly reported

The most frequently reported effects of puberty-pausing medication are physical and short-term. The Mayo Clinic lists swelling at the injection site, weight gain, hot flashes, headaches, and mood changes as the possible side effects of this treatment. These effects tend to resolve once a young person adjusts to treatment or stops the medication, and most clinics reassess a young person's experience at every follow-up visit.

Clinicians also watch for a less visible effect. The American Academy of Pediatrics has acknowledged that pubertal suppression is not without risks: delaying puberty beyond one’s peers can be stressful and can contribute to lower self-esteem and increased risk-taking. That acknowledgment is why regular care-team check-ins are standard, not optional.

Because the medication pauses puberty rather than reversing it, some of what looks like a "side effect" is actually the expected, intended effect: a slowing or pausing of physical changes like breast development, voice deepening, or growth spurts. Clinicians distinguish this expected pause from the smaller set of physical symptoms, like headaches or fatigue, that are considered true side effects. TransHealthHub's page on side effects and monitoring walks through what is commonly reported versus what is closely watched.

How bone density is affected and monitored

Bone density is the effect that clinicians monitor most closely, and it is also the one most often misunderstood. A 2020 study of 63 early-pubertal transgender youth at four U.S. academic pediatric gender centers found that a meaningful share already had lower bone density scores before starting treatment at all, with at least one low score in 30 percent of youth designated male at birth (10 of 33) and 13 percent of youth designated female at birth (4 of 30), a small sample that makes these figures imprecise. That timing matters: because the lower scores were measured before puberty suppression began, they cannot be attributed to the medication itself.

Once treatment starts, bone density is something a care team actively manages rather than leaves to chance. The Mayo Clinic notes that yearly bone density and bone age tests may be recommended, along with calcium and vitamin D as needed, and that height is typically checked every few months during treatment. TransHealthHub's page on bone density research covers when scores typically recover after hormone therapy begins, and where researchers say more follow-up data is still needed.

Fertility, growth, and other effects doctors watch

Fertility is one of the most common questions families ask, and it is also one of the most individual. How puberty-pausing medication affects future fertility depends heavily on when in puberty a young person starts treatment and how long they stay on it. The Endocrine Society's clinical practice guideline instructs clinicians to counsel every young person on fertility preservation options before puberty suppression begins, precisely because starting earlier in puberty can narrow those options later. TransHealthHub's page on fertility preservation walks through what that counseling can look like at different stages.

Growth is monitored for a related reason: this medication pauses the pubertal growth spurt along with everything else, so care teams track height regularly to make sure growth stays on an expected path. The same guideline calls for clinical checkups every three to six months and lab work every six to twelve months once a young person is also using hormone therapy, giving families a predictable schedule rather than a one-time decision.

What the research says about mental health

Because concerns about this medication are sometimes framed around mental health, it is worth looking at what the evidence actually shows. A 2026 study in JAMA Network Open examined insurance claims for more than 231,000 U.S. youth ages 10 to 17, including over 41,000 transgender youth, and found that a prescription for this medication was associated with lower odds of being diagnosed with a mood disorder and lower odds of suicidal thoughts or behaviors, compared with transgender youth who did not receive one. The study's authors were careful to note that claims data show associations, not proof of cause and effect, and that further research is still needed. That caution matters and should be preserved whenever this finding is cited.

This is consistent with the position of major U.S. medical groups. The American Medical Association, American Academy of Pediatrics, American Psychological Association, and Endocrine Society all regard this type of care, prescribed and monitored by a qualified clinician, as medically necessary and evidence-based for adolescents with persistent gender dysphoria. That position does not mean every question has been settled. Long-term data, especially multi-year bone density and psychological outcomes past adolescence, remains an active area of research, and TransHealthHub tries to say so plainly rather than overstate what is known in either direction.

What's tracked and what the evidence shows, at a glance

What's tracked	What's typically seen	How it's monitored
Short-term physical effects	Injection-site swelling, hot flashes, headaches, mood changes, weight gain	Reviewed at routine follow-up visits
Bone density	Some youth show lower scores even before treatment begins; density is closely tracked during treatment	Yearly bone density and bone age tests, plus calcium and vitamin D as needed
Growth	Pubertal growth spurt is paused along with other changes	Height checked every few months
Fertility	Effects depend on timing and duration of treatment	Fertility preservation counseling before treatment starts
Mental health	Associated with lower odds of mood disorder and suicidal thoughts diagnoses in one large U.S. study	Ongoing clinical follow-up and further research

Frequently asked questions

What are the most common puberty blocker side effects? The most commonly reported effects are physical and temporary: injection-site swelling, hot flashes, headaches, mood changes, and weight gain, according to the Mayo Clinic. The changes that require longer-term monitoring, bone density, growth, and fertility, are tracked through scheduled tests rather than reported as day-to-day symptoms.

Are the effects of puberty-pausing medication permanent? The medication itself is designed to pause puberty rather than cause permanent change, and pubertal development typically resumes if the medication is stopped. Bone density and fertility effects depend on how early in puberty treatment starts and how long it continues, which is why clinicians monitor both throughout treatment.

Does puberty-pausing medication affect mental health? A large 2026 U.S. study found this medication was associated with lower odds of a mood disorder or suicidal thoughts diagnosis among transgender youth, though the study's authors note this reflects an association rather than a proven cause. Ongoing monitoring and further research are part of standard, responsible care.